|
|
Volumn 34, Issue 3, 2002, Pages 420-422
|
|
The United States Food and Drug Administration and the end of antibiotics [5]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTIC AGENT;
DALFOPRISTIN PLUS QUINUPRISTIN;
LINEZOLID;
ANTIBIOTIC THERAPY;
BIOEQUIVALENCE;
CLINICAL TRIAL;
DRUG DESIGN;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG RESEARCH;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE QUALITY;
LETTER;
MEDICAL RESEARCH;
PRIORITY JOURNAL;
STANDARDIZATION;
STATISTICAL ANALYSIS;
UNITED STATES;
ANTI-BACTERIAL AGENTS;
CLINICAL TRIALS;
DRUG APPROVAL;
DRUG INDUSTRY;
HUMANS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 0036467238
PISSN: 10584838
EISSN: None
Source Type: Journal
DOI: 10.1086/334577 Document Type: Letter |
|
Times cited : (54)
|
|
References (3)
|
